Since the identification of FLCN as a tumour suppressor whose disruption is responsible for BHD syndrome, considerable effort has been focused on understanding the underlying molecular mechanisms that lead to disease. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.